Insulia® is a prescription-only software medical device intended for use by healthcare professionals and their type 2 adult diabetes patients treated with long-acting insulin analogs as an aid in the management of diabetes. Please carefully read product instructions before use. Insulia is only indicated for use with insulin detemir (Levemir® U-100) once or twice daily, insulin degludec (Tresiba® U-100) once daily and insulin glargine (Lantus® U-100, Toujeo® U-300 and Basaglar® U-100) once daily. Insulia should not be used for basal dose recommendations with intermediate-acting insulin (NPH – Neutral Protamine Hagedorn) nor with premixed insulin. Insulia is not intended for use by pregnant women, non-adult patients or patients that are treated with a basal-plus or a basal-bolus regimen (i.e. including multiple mealtime insulin injections per day or insulin pump therapy).
©2019 Voluntis. All rights reserved. For distribution in US only. Insulia is a registered trademark of Voluntis.